Ekso Bionics (NASDAQ:EKSO) Price Target Raised to $10.00 at HC Wainwright

Ekso Bionics (NASDAQ:EKSO) had its target price raised by HC Wainwright from $9.25 to $10.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock.

Separately, StockNews.com upgraded Ekso Bionics from a “sell” rating to a “hold” rating in a report on Thursday, April 4th.

Ekso Bionics Stock Up 3.2 %

EKSO stock opened at $1.29 on Tuesday. The stock has a market capitalization of $23.09 million, a P/E ratio of -1.17 and a beta of 1.61. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.87 and a current ratio of 2.49. Ekso Bionics has a one year low of $0.62 and a one year high of $3.13. The company has a 50 day moving average price of $1.50 and a two-hundred day moving average price of $1.62.

Ekso Bionics (NASDAQ:EKSO) last released its earnings results on Monday, March 4th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.11). The firm had revenue of $4.85 million during the quarter, compared to analysts’ expectations of $4.80 million. Ekso Bionics had a negative return on equity of 90.80% and a negative net margin of 83.14%. During the same period in the previous year, the firm posted ($0.24) earnings per share. As a group, sell-side analysts expect that Ekso Bionics will post -0.49 EPS for the current year.

Institutional Trading of Ekso Bionics

A hedge fund recently bought a new stake in Ekso Bionics stock. Kent Lake Capital LLC purchased a new position in shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 141,158 shares of the company’s stock, valued at approximately $353,000. Kent Lake Capital LLC owned 0.95% of Ekso Bionics at the end of the most recent quarter. 6.42% of the stock is currently owned by institutional investors and hedge funds.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.